ANGIOTECH ANNOUNCES POSITIVE ADHIBIT DATA TO PREVENT SURGICAL ADHESIONS

Angiotech Pharmaceuticals recently announced positive results from a European pivotal clinical study conducted to evaluate the safety and efficacy of Adhibit Adhesion Prevention Gel for the reduction of surgery induced scars (adhesions) that can occur after surgery to remove fibroids from the uterus (myomectomy surgery).
PRNewswire